VSQM
WST icon

V-Square Quantitative Management’s West Pharmaceutical WST Stock Holding History

V-Square Quantitative Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$877K Sell
2,442
-246
-9% -$75.2K 0.08% 213
2026
Q1 		$674K Buy
2,688
+351
+15% +$87.3K 0.07% 243
2025
Q4 		$643K Buy
+2,337
New +$639K 0.07% 251
2025
Q3 		– Sell
-2,486
Closed -$544K – 598
2025
Q2 		$544K Buy
2,486
+120
+5% +$25.7K 0.07% 283
2025
Q1 		$530K Buy
2,366
+283
+14% +$78K 0.08% 285
2024
Q4 		$682K Sell
2,083
-3
-0.1% -$944 0.1% 217
2024
Q3 		$626K Buy
2,086
+146
+8% +$44.7K 0.09% 241
2024
Q2 		$639K Buy
1,940
+334
+21% +$118K 0.1% 197
2024
Q1 		$636K Buy
1,606
+302
+23% +$112K 0.09% 210
2023
Q4 		$459K Buy
1,304
+322
+33% +$114K 0.08% 235
2023
Q3 		$368K Buy
982
+541
+123% +$209K 0.16% 149
2023
Q2 		$169K Buy
+441
New +$158K 0.12% 161

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

V-Square Quantitative Management's WST Position: Q2 2026 in Review

V-Square Quantitative Management reduced its West Pharmaceutical (WST) stake by 9.2% in Q2 2026, selling an estimated $75.2K and leaving 2,442 shares worth $877K. The position accounts for 0.08% of the portfolio, ranked #213.

V-Square Quantitative Management first reported a position in WST in Q2 2023 and has held it in 12 quarters since. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • V-Square Quantitative Management held 2,442 shares of West Pharmaceutical worth $877K as of Q2 2026.
  • V-Square Quantitative Management sold 246 West Pharmaceutical shares in Q2 2026, an estimated $75.2K.
  • West Pharmaceutical made up 0.08% of V-Square Quantitative Management's portfolio in Q2 2026, its #213 holding.
  • V-Square Quantitative Management first reported a position in West Pharmaceutical in Q2 2023 and has held it in 12 quarters since.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on V-Square Quantitative Management's 13F filing for Q2 2026, filed 27 Jul 2026.